Derived from our findings that high protein levels of Jab1/COPS5 in primary untreated tumor specimens might help to identify lung cancer patients in whom chemotherapy resistance and the potentially improved efficacy of Jab1/COPS5-inhibition may balance toxicities and side effects of anti-cancer treatment. This evidence concerns the gene COPS5 and neoplasm.